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Abstract
The number of immigrants entering the United States has increased dramatically in the past 30
years, but minorities and ethnic groups are underrepresented in research studies. This study
examined first- and second-generation Arab American immigrants in Dearborn, Michigan, using
a survey from 65 participants to determine the impact of generation on clinical research
participation. Fifty-one (78%) of the respondents were first-generation immigrants, and 14 (22%)
were second generation. There was no statistical difference between first- and second-generation
immigrants in their willingness to participate in clinical research. Further research with a larger
and more diverse population is needed to evaluate willingness to participate in clinical trials by
generation in Arab Americans.
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Chapter 1: Introduction
There is a growing population of immigrants in the United States, estimated to be 13.3%
as of 2014 (Camarota & Zeigler, 2016). In 2017, there were over 43 million residents who were
immigrants in the United States, which makes up 13.4% of the total population (López & Bialik,
2017).
Among these immigrants, the Arab American population is the fastest-growing
population in the United States (Haddad, Al-Bashaireh, Ferrell, & Ghadban, 2017). According to
the US Census (2010), Arab Americans constitute more than 3.7 million people in the United
States. An Arab born in a foreign country but living in the United States is considered an
immigrant. An immigrant can be a first- or second-generation immigrant. First generation is
defined as “an immigrant, a foreign-born resident who has relocated and become a citizen or
permanent resident, in a new country” (Moffett, 2017, p.4). Second generation is defined as “an
individual who was naturally born in the relocated country to one or more parents who were born
elsewhere and are not U.S. citizens living abroad” (Moffett ,2017, p.4). Many of these Arab
American immigrants have relocated to the United States in order to improve their living
conditions. Among those improvements is access to healthcare tailored to meet their needs. Since
different genetic groups are affected by certain diseases more than other groups, it is important to
provide treatment options to Arab Americans based on their genetic makeups. Unfortunately,
research focusing on or recognizing Arab Americans as a group is lacking.
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There are barriers that exist in clinical research for both the participant and the
researcher, especially in ethnic minorities. Barriers to participation can include:
misunderstanding of cultural knowledge, beliefs of others from a different cultural background,
lack of trust in the healthcare system, difficulty understanding the language, or lack of awareness
of limited available resources, such as transportation or child care. In fact, one of the major
barriers in clinical research is the lack of knowledge about the cultural differences among
immigrants. In order to improve participation rates, one should understand cultural and language
differences (George, Duran & Norris, 2014) that impact an individual’s willingness to participate
in clinical trials. Furthermore, despite these barriers, participation in clinical research needs to be
culturally diverse to be able to improve immigrants’ participation in clinical trials in order to
bridge the gap in health care and research (Hershenberg, Drabick & Vivian, 2012)
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Chapter 2: Background
Immigrants in the United States must overcome many challenges (Jaber, 2002). These
include barriers such as language, culture, and religion. There is a need to educate immigrants in
the United States about the value of participation in clinical research. Failure to do so could
result in a loss of valuable findings in epidemiological studies.
In a study conducted by (Han, Kang, & Kim, 2006). 14 studies were analyzed which included
2,400 Korean Americans. Their study focused on multiple challenges faced by Korean
Americans such as recruitment barriers. In review of the findings from the study, the authors
determined that two factors contribute to participation barriers. These two factors were found at
the individual and community level. At the individual level, they found that cultural attitudes,
language, gender, and age played a role, and at the community level, reduced healthcare
coverage, lack of awareness, lack of education regarding healthcare prevention, the
inability/reluctancy of gatekeepers to educate and advise, and the types of research all
contributed to the barriers faced by research on immigrants.
The research conducted by Salman, Nguyen, & Lee, (2016); focused on data obtained from
research regarding cancer patients. In all, they chose 28 articles to review with eight being written
by nurses. In the context of their review, Salman et al. (2016) found that three barriers were related
to the lack of immigrant outcome: physician, patient, and system related conflicts. According to
the authors, the physicians were hindering the process by several mechanisms which stemmed
from their lack of awareness, attitudes towards the trials, bias, lack of communication, and concern
regarding the cost to patients. On the patient level, age, gender, ethnicity, socioeconomic status,
and perceptions all contributed to the lack of participation.
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Finally, the system at large was responsible for the unfortunate outcome because it failed
in the areas of design, inclusion/exclusion, and access/cost of health care to participants. According
to these authors, overcoming these barriers will help to increase participation in the future.
According to Smith et al. (2018), the major contributing factor raising the barriers to
clinical research stems from lack of communication in the immigrant’s native language. After
conducting research on 19,453 cancer patients over a 10- year period, the authors divided their
sample into three groups: English- speaking patients (non-CALD), culturally and linguistically
diverse patients whose preferred language was English (CALD-PLE), and culturally and
linguistically diverse patients whose preferred language was not English (CALD-PLNE). Among
these groups, it was found that language barriers contributed to the lack of participation in
clinical trials. Of the 19,453 patients analyzed, 10,675 (54.9%) of the participants were
categorized as non-CALD; 3,217 (16.5%) were CALD-PLE; and 3,601 (18.5%) were
categorized as CALD-PLNE. Of the non-CALD patients, 8.4% were enrolled in a study, while
91.6% were not. Of the CALD-PLE patients, 7.7% were enrolled while 92.3% were not. Lastly,
of the CALD-PLNE patients, 3.9% were enrolled while 96.1% were not. Only 50% of the
patients who communicated less easily in English participated in a study. These authors
concluded that the results indicated that a growing need for better communication within the
field was warranted.
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Purpose of the Study
The objectives of this study were to evaluate the willingness of individuals who were
first- or second-generation immigrants to participate in clinical trials.
Research Question 1.
Is there a difference in willingness to enroll in clinical research studies between first- and
second-generation immigrants?
Research Question 2.
Is there a difference in participation based on age, gender, or education?
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Chapter 3: Research Design and Methodology
The study survey was approved by the University Human Subjects Review Committee
(UHSRC) at Eastern Michigan University (Appendices A and B). To participate in this study,
participants had to agree to the terms of the consent form (Appendices C and D).
This study was designed to evaluate the willingness of individuals who were first- or
second-generation immigrants to participate in clinical trials.
After obtaining approval from the UHSRC at Eastern Michigan University for this study
survey, and after the participants agreed to the terms of the study via consent forms, a random
survey questionnaire was emailed to 250 members of the Al-Salam Islamic Center in Dearborn,
Michigan, in May 2018, available in both English and Arabic (Appendices E and F).
The survey consisted of 18 questions in total and included demographic questions such as
age, gender, marital status, and education.
The primary endpoint was to discover if there is a difference between second-generation
and immigrants in willingness to enroll in clinical research. The secondary endpoint was to
determine if there is a difference in potential participation based on any demographic variable.

Immigrants Participation in Clinical Trial

Data Analysis:
Data collected from the survey were initially entered into Microsoft Excel. Later these
data were uploaded to Statistical Package for the Social Sciences (SPSS) v25 format, in which
each question and its options were categorized into ordinal and nominal data. The transcribed
data were analyzed for demographic variables and other possible parameters to answer the
research questions. Responses from first- and second-generation immigrants were grouped for
analysis. Data analysis was conducted using the Pearson’s chi-square test and Fisher’s exact test
to evaluate the data and examine differences between groups. It should be noted that the alpha
level used for all tests of significance was α = .05. Correlations were explored for the generation
variable in relation to other variables.
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Chapter 4: Results
The survey conducted included an analysis of 65 individuals that agreed to participate
from the 250 that were emailed. Fifty of the responses were in the English version and the other
15 in the Arabic version. The response rate was 26%. According to this survey, 56 (86%) of the
participants were immigrants, and nine (13.8%) were non-immigrants. Of those immigrants, 51
(78%) were first generation (“Generation 1”), 10 (21.5%) were second (“Generation 2”)
participants, and four were third generation (“Generation 3”) participants. Forty (61%) of the
respondents were between the ages of 18 and 34, which includes 30 participants from first
generation and 10 from second and third generations. Thirty-five (53.8%) of the participants
from first generation and 10 (78.6%) from second generation or more had a bachelor’s degree or
greater. The majority (41;63%) of first-generation participants were of Middle Eastern
nationality. In addition, 63 (97%) of the individuals who participated in the survey were Muslim
across all generations. A more detailed result of demographic data is presented in Table 1.
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Table 1: Demographic Characteristics of Survey Participants

Gender

Females
Males

n = 44 (68%)
n = 21 (32%)

Age

18-24
25-34
35-64
>65

n = 19 (29%)
n = 2 (32%)
n = 22 (34%)
n = 4 (6%)

Level of Education

High School or Less
Associate’s Degree
Bachelor’s Degree
> Master’s Degree

n = 9 (13.8)
n = 6 (9%)
n = 40 (61.5%)
n = 11 (16.9%)

US
Yemen
Iraq
Middle Eastern
Other
Protestant
Catholic
Muslim
Jewish
Buddhist
Other/no answer

n = 11 (16.9%)
n = 6 (9.2 %)
n=0
n = 41 (63%)
n = 3 (4.6%)
n = 1 (1 %)
n = 1 (1%)
n = 63 (97%)
n=0
n=0
n=1 (1.5%)

Married
Single
Prefer not to answer

n = 29 (44.6%)
n = 34 (52%)
n = 2 (3%)

Nationality

Religion

Marital Status

Of the 65 individuals who participated in the survey, there were 51 first-generation
immigrants, of whom 36 (70.6%) were females. In addition, there were six males and eight
females from second and third generations. Thus, overall 68% of the participants were females.
A chi-square analysis comparing participant’s generation and gender revealed a p-value of 0.056
(see Figure 1). This means that more than 50% of the participants were females from both
generations.
A number of notable demographic differences across all generations were seen. First,
more Generation 1 participants were included in the study. In addition, more female participants
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were included in the study from first generation than second and third generation. Furthermore,
the average age for most of first-generation participants was between 18 and 34.

Figure 1. Participants’ gender compared by generation.
Of those who participated, 26 (51%) from Generation 1 said they would be willing to
participate in future clinical trials, and 25 (49%) declined. Seven (50%) of the second-generation
participants said they would be willing to participate in future clinical research, and the other
50% declined. When participants were asked reasons for their willingness to participate in future
clinical trials, 23 (35%) of first-generation participants said, “If I get paid,” and 17 (26%) said
“to help future generations.” Furthermore, 16 (24.6%) from second generation said, “I don’t
want to be used as a guinea pig,” and nine (13.8%) selected the most common reason for not
willing to participate as “I do not know if it would be safe” (see Table 2).

Table 2 Reasons for Considering Participating or Not Participating in a Clinical Trial
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Reasons for
Participating

n (%)

Generation

Reasons for
not
participating

n (%)

Generation

If I get paid

21 (32.3%)

First
generation

I do not want
to be used as
a guinea pig

10 (15.3%)

Generation 1

I do not know
if it would be
safe

29 (44.6%)

23 (35%)

To help
future
generations

28 (43%)

First
generation
17 (26%)

16 (24.6%)

Generation 2
9 (13.8%)

When the question “How knowledgeable are you about clinical research?” was asked, 40
(78%) respondents from Generation 1 had at least a little knowledge about clinical trials, and
eight (15.6%) from Generation 1 had no knowledge of clinical trials. In addition, 10 (71.4%)
respondents from Generation 2 who had at least a little knowledge about clinical research and
one (7%) respondent who was completely knowledgeable about clinical research (Table 3).
A Spearman’s rank-order correlation revealed a weak correlation between the variables
generation and knowledge (p = .056). In addition, participants across both genders and both
generations had little knowledge of clinical trials. Another Spearman’s rank-order correlation
showed a positive significance for a relationship between knowledge and outcome (p = .033).

Table 3
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Knowledge About Clinical Trials by Generation

Knowledge

Generation 1

Generation 2

n (%)

n (%)

Not at all knowledgeable

8 (15.6%)

3 (21%)

A little knowledgeable

20 (39%)

4 (28.5%)

Somewhat knowledgeable

20 (39%)

6 (42.8%)

When the participants in this survey were asked, “What is your highest level of
education?” 35 (68.6%) from Generation 1 had a bachelor’s degree or more, and 16 (31.4%) had
an associate’s degree or less. There were 11 (78.6%) from Generation 2 with a bachelor’s or
more and 4 (21.4%) with an associate’s or less (see Figure 2).
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Figure 2. Participants level of education by generations.
A Fisher’s exact test was done to compare participants education with generation to
determine if the level of education impacted one generation more than the other. Results indicate
that 51 (78.4%) of first-generation participants had an associate’s or more. A chi-square analysis
revealed a statistically significant correlation (p = .003).
When the question was asked, “If given a chance, would you consider participating in a
clinical research study?” 26 (40%) individuals from Generation 1 said “yes” and 25 (38%) said
“no.” In addition, seven (50%) from Generation 2 said “yes,” and the other 50% said “no.”
Furthermore, when participants were asked, “Would you take a drug that was not tested in
animal or humans?” 47 (90%) respondents declined.
When the participants were asked “How would you like to be informed about clinical
trials?” a majority 44 (67.7%) of the respondents from Generation 1 preferred to be informed
through a physician and seven (10.8%) from other forms. There were eight (12.3%) respondents
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from Generation 2 who also preferred to be informed through a physician and six (9.2%)
individuals who would like to be informed through other ways. chi-square analysis was
conducted and a statistical significance was determined. It should also be noted that this
significance had a medium effect size according to the Cramer’s V analysis. X2(1) = 5.826, p =
0.016, φ = 0.299. This clearly indicates that the majority of first-generation participants wanted
to be informed about clinical trials through a physician (see Table 4).
Table 4
How Participants Preferred to Be Informed by Generation

Participants informed by

First Generation

Second Generation

Physician

44 (67.7%)

8 (12.3%)

Other

7 (10.8%)

6 (9.2%)
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Chapter 5: Discussion
The purpose of this study was to identify any differences in willingness to participate in
clinical trials between first- and second-generation Arab American immigrants. The results
indicate more first-generation (n = 51) Arab Americans responded to the survey than secondgeneration (n = 14) Arab Americans. Perhaps first-generation immigrants are trying hard to adapt
to new cultures and do all the necessary tasks to fit in; however, it is difficult to make the
assumption that one generation is more willing to participate in clinical trials than the other with
this small population sample. An equal and larger sample size is needed in order to make an
accurate comparison.
The current survey was emailed to both males and females at the Islamic center.
However, more female participants responded to the survey. There is an improvement in the
number of female participants in clinical trials from past decades (Scott et al., 2018).
Furthermore, despite the fact that the Arab population is the fastest growing population in the
United States, they continue to be underrepresented when it comes to clinical research, especially
Arab women. Arab immigrants in the United States struggle to acculturate successfully because
of their culture and beliefs.
The survey results also revealed that a majority of the participants were between the age
of 18 and 34 for first generation; perhaps if we had more participants that were 35 or older for
first generation, they may prove to have a different result. Older participants may be more
willing to participate in clinical trials, especially if it came from their physician, where they have
better trust and understanding of the clinical research. On the contrary, the present age group
from first generation who did respond to the survey may have incorrectly answered the
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questions. For example, when participants were asked “What are clinical trials?” 11% said they
were not sure.
The majority (n = 63; 97%) of the participants were Muslim, with the exception of two
participants: one Protestant Christian and one participant who preferred not to answer. The results
are within the expected outcome considering the survey was conducted at a mosque, which is
where Muslims practice their religion. However, the Protestant Christian could have been an
employee at the Islamic center, as you do not have to be a Muslim to be employed at the center.
Furthermore, 41 (61.5%) of the participants were of Middle Eastern descent. The geographical
location of where the study was conducted may have impacted the results. Dearborn city is a
home to one of the largest Middle Eastern Muslim population in the United States.
A correlational assessment was conducted to compare generations and participants’
knowledge of clinical research. However, the question about the participants’ knowledge had too
many factors for a small sample size. Therefore, the categories had to be re-grouped into two
groups: “not knowledgeable” or “somewhat knowledgeable” about clinical research (Table 3).
Twenty-two (33.8%) respondents from Generation 1 had at least little knowledge about clinical
trials, while contrarily, 29 (44.6%) of first generation had no knowledge of clinical trials. In
addition, seven (10.8%) respondents from Generation 2 had at least a little knowledge about
clinical research and seven (10.8%) were not knowledgeable about clinical research. A chisquare analysis revealed a statistically significant result at p = .004 (Figure 2). Similarly,
education had to be re-grouped into two groups; associate’s or less and bachelor’s or more,
because of the low number of participants in this survey. The results revealed that 35 (68.6%) of
first-generation respondents had a bachelor’s or more and 11 (78.6%) of the second-generation
respondents that also had a Bachelor’s or more with a statistically significant p = .003 (Figure 3).
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This indicates that this particular group that was surveyed was well educated. These findings
indicate that despite the fact that this particular population sample was well educated, the
participants may not be knowledge about clinical research. Other literature shows that one of the
major reasons for lack of participation in clinical trials among Arab populations is not being
informed or knowledgeable about research (Tohid, et al., 2017). Furthermore, when participants
were asked how they would like to be informed about clinical research, 44 (67.7%) of firstgeneration respondents and eight (12.3%) respondents from the second generation said through a
physician (Figure 4). This indicates that if information is received from a physician, it may
increase their chance of participation in clinical trials: “Patients’ decisions regarding trial
participation may be influenced by the information they receive” (Moorcraft et al., 2016, P.2).
Of the sixty-five surveyed participants, the major reason for willingness to participate in
clinical research was to help future generations (n = 28; 43%). These findings are consistent with
studies conducted by Moorcraft et al. (2016), which revealed the major reasons that influence a
patient’s willingness to participate in clinical research is to benefit others. Additionally, the
major reason for not willing to participate was out of concern that it would not be safe (n = 29;
44.6%). It is challenging when it comes to recruiting subjects to participate in clinical trials as
fear and mistrust exist in the Arab population (Tohid, et al., 2017).
In a previous study conducted by Tohid et al. (2017), where 2,379 Arab participants were
studied in Doha, Qatar to assess the attitudes towards participation in clinical research, their
findings revealed three main reasons for declining to participate in clinical research: time
constraint, fear, and lack of being informed.
The overall study may have obtained better results if there had been a tutorial explaining
the study prior to taking the survey online, or if it was given in-person, with one-on-one
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instructions. In addition, some of the questions in the survey could have been improved or
eliminated, such as marital status, did not have any value in the survey. Additionally, the
question about reasons why you might agree or not agree to participate in clinical research could
have been combined into one question.
To improve participation among immigrants and minorities in clinical trials, researchers
should invest in strategies to overcome cultural barriers that exist in clinical research and
provide future interventions.
Limitations of the Study:
•

The sample size was small and uneven between the generational groups.

•

Due to the low response by both generations, some variables had to be collapsed for
analyses.
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Chapter 6: Conclusion
In summary, the overall study was conducted among 65 participants to identify if firstgeneration immigrants were more willing than second-generation immigrants to participate in
clinical trials. The survey consisted of 18 questions in all. Our study findings conclude that no
differences were seen between generational willingness to participate in clinical research. This is
likely due to the small number of second-generation respondents. There were trends seen,
however, as it appears that Muslim women were more willing to answer survey questions than
Muslim men. The impact of this differential response rate on the survey results is unknown. It is
also unknown whether face-to-face surveys might have improved response rate overall and the
response rate of men in particular. Additional research is warranted. Our hypothesis that firstgeneration immigrants are more willing than second-generation immigrants to participate in
clinical trials requires a larger and sample size in with better representation from both
generations.
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Appendix A: Response Letter from EMU Human Subject Review Committee
Mar 21, 2018 10:49 AM EDT
Aisha Farha
Eastern Michigan University, School of Health Sciences
Re: Initial - UHSRC-FY17-18-328 Are First Generation Immigrants More Inclined to Participate
in Clinical Research Dear Aisha Farha:
The Eastern Michigan University Human Subjects Review Committee has rendered the decision
below for Are First Generation Immigrants More Inclined to Participate in Clinical Research.
Decision: Minor Stipulations
Findings: Please respond to all comments in the application. Click "reply" to register and save
your response. For changes in any of the supplemental documents, make changes in Track
Changes mode or highlight all changes in the revised documents so that they can be easily seen.
If you make any additional changes or do not address all of the comments, please include a letter
explaining the changes and why you did not address specific comments.
Please make any required revisions to the Cayuse IRB application and study documents and
upload the revised documents in the Cayuse IRB application. Once your revisions are complete,
the UHSRC will review your revisions and render a decision.
You are not approved to conduct human subject research on this study. You may not begin your
research until you receive an approval letter.
Please contact human.subjects@emich.edu with any questions or concerns. Sincerely,
Eastern Michigan University Human Subjects Review Committee
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Appendix B: Approval Letter after Sample Size Modification
May 16, 2018 9:53 AM EDT
Aisha Farha
Eastern Michigan University, School of Health Sciences
Re: Modification - UHSRC-FY17-18-328 Are First Generation Immigrants More Inclined to
Participate in Clinical Research
Dear Aisha Farha:
The Eastern Michigan University Human Subjects Review Board has rendered the decision
below for Are First Generation Immigrants More Inclined to Participate in Clinical Research.
Decision: Exempt
Findings:
Contact human.subjects@emich.edu with questions and concerns.
Sincerely,
Eastern Michigan University Human Subjects Review Committee
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Appendix C: Informed Consent Form (English Version)

Informed Consent Form
Project Title: Immigrant status and participation in clinical research
Principal Investigator: Aisha Farha at Eastern Michigan University
Invitation to participate in research
You are invited to participate in a research study. In order to participate, you must be 18 years of
age or older. Participation in research is voluntary. Please ask any questions you have about
participation in this study.
What is this study about?
The objective of this study is to identify the willingness of immigrants to participate in clinical
research.
What will happen if I participate in this study? Participation in this study involves answering
questions related to research, which will help me understand -immigrants understanding of and
their attitude towards research.
What are the expected risks for participation?
There are no expected physical or psychological risks to participation.
Are there any benefits to participating?
You will not directly benefit from participating in this research.
How will my information be kept confidential?
As we are not collecting subjects’ names on the survey sheet, your information will therefore be
confidential. If you answer the questions verbally, the questioner will make no notation of your
identity on the survey sheet.
Storing study information for future use
We WILL NOT store your information to study in the future. Your information will be labeled
with a code and not your name. Your information will be stored in a password-protected or
locked file.
What are the alternatives to participation?

Immigrants Participation in Clinical Trial

28

The alternative is not to participate.
Are there any costs to participation?
Participation will not cost you anything.
Will I be paid for participation?
You will not be paid to participate in this research study.
Study contact information
If you have any questions about the research, you can contact the Principal Investigator,
Afarha4@emich.edu. You may also contact my advisor, Dr. Irwin Martin at Eastern Michigan
University, imartin2@emich.edu
For questions about your rights as a research subject, contact the Eastern Michigan University
Human Subjects Review Committee at human.subjects@emich.edu or by phone at 734-4873090.
Voluntary participation
Participation in this research study is your choice. You may refuse to participate at any time,
even after signing this form, without repercussion. You may choose to leave the study at any
time without repercussion.
Statement of Consent
I have read this form. I have had an opportunity to ask questions and am satisfied with the
answers I received. I give my consent to participate in this research study.
Signatures:

______________________________________
Signature of Subject

____________________
Date

I have explained the research to the subject and answered all his/her questions. I will give a copy
of the signed consent form to the subject.
________________________________________
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Name of Person Obtaining Consent
________________________________________
Signature of Person Obtaining Consent

_______________________
Date
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)Appendix D: Informed Consent Form (Arabic Version
ﻣﻮاﻓﻘﺔ ﻣﺴﺒﻘﺔ
وﺿﻊ اﻟﻤﮭﺎﺟﺮﯾﻦ واﻟﻤﺸﺎرﻛﺔ ﻓﻲ اﻟﺒﺤﻮث اﻟﺴﺮﯾﺮﯾﺔ
دﻋﻮة ﻟﻠﻤﺸﺎرﻛﺔ ﻓﻲ اﻟﺒﺤﺚ
أﻧﺖ ﻣﺪﻋﻮ ﻟﻠﻤﺸﺎرﻛﺔ ﻓﻲ دراﺳﺔ ﺑﺤﺜﯿﺔ .ﻣﻦ أﺟﻞ اﻟﻤﺸﺎرﻛﺔ  ،ﯾﺠﺒﺄن ﯾﻜﻮن ﻋﻤﺮك  ١٨ﻋﺎًﻣﺎ أو أﻛﺜﺮ .اﻟﻤﺸﺎرﻛﺔ ﻓﻲ اﻟﺒﺤﻮث
طﻮﻋﯿﺔ .ﯾﺮﺟﻰ طﺮح أي أﺳﺌﻠﺔ ﻟﺪﯾﻚ ﻋﻦ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ
ﻣﺎ ھﻲ ھﺬه اﻟﺪراﺳﺔ ﺣﻮل؟
اﻟﮭﺪف ﻣﻦ ھﺬه اﻟﺪراﺳﺔ ھﻮ ﺗﺤﺪﯾﺪ رﻏﺒﺔ اﻟﻤﮭﺎﺟﺮﯾﻦ ﻓﻲ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ اﻟﺒﺤﻮث اﻟﺴﺮﯾﺮﯾﺔ
ﻣﺎ ھﻲ اﻟﻤﺨﺎطﺮ اﻟﻤﺘﻮﻗﻌﺔ ﻟﻠﻤﺸﺎرﻛﺔ؟
ﻻ ﺗﻮﺟﺪ ﻣﺨﺎطﺮ ﺟﺴﺪﯾﺔ أو ﻧﻔﺴﯿﺔ ﻣﺘﻮﻗﻌﺔ ﻟﻠﻤﺸﺎرﻛﺔ
ھﻞ ھﻨﺎك أي ﻓﻮاﺋﺪ ﻟﻠﻤﺸﺎرﻛﺔ؟
ﻟﻦ ﺗﺴﺘﻔﯿﺪ ﺑﺸﻜﻞ ﻣﺒﺎﺷﺮ ﻣﻦ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬا اﻟﺒﺤﺚ
ﻛﯿﻒ ﺳﯿﺘﻢ اﻟﺤﻔﺎظ ﻋﻠﻰ ﺳﺮﯾﺔ ﻣﻌﻠﻮﻣﺎﺗﻲ؟
ﻧﻈًﺮا ﻷﻧﻨﺎ ﻻ ﻧﺠﻤﻊ أﺳﻤﺎء اﻟﻤﻮاﺿﯿﻊ ﻋﻠﻰ ورﻗﺔ اﻻﺳﺘﺒﯿﺎن ،ﻓﺴﺘﻜﻮن ﻣﻌﻠﻮﻣﺎﺗﻚ ﺳﺮﯾﺔ .إذا أﺟﺒﺖ ﻋﻠﻰ اﻷﺳﺌﻠﺔ ﺷﻔﮭﯿﺎ  ،ﻟﻨﯿﻘﻮم
اﻟﺴﺎﺋﻞ ﺑﺘﺪوﯾﻦ ھﻮﯾﺘﻚ ﻋﻠﻰ ورﻗﺔ اﻻﺳﺘﺒﯿﺎن
ﺗﺨﺰﯾﻦ ﻣﻌﻠﻮﻣﺎت اﻟﺪراﺳﺔ ﻟﻼﺳﺘﺨﺪام ﻓﻲ اﻟﻤﺴﺘﻘﺒﻞ
ﻟﻦ ﻧﻘﻮم ﺑﺘﺨﺰﯾﻦ ﻣﻌﻠﻮﻣﺎﺗﻚ ﻟﻠﺪراﺳﺔ ﻓﻲ اﻟﻤﺴﺘﻘﺒﻞ .ﺳﺘﺘﻢ ﺗﺴﻤﯿﺔ ﻣﻌﻠﻮﻣﺎﺗﻚ ﺑﺮﻣﺰ وﻟﯿﺲ ﺑﺎﺳﻤﻚ .ﺳﯿﺘﻢ ﺗﺨﺰﯾﻦ اﻟﻤﻌﻠﻮﻣﺎت
اﻟﺨﺎﺻﺔ ﺑﻚ ﻓﻲ ﻣﻠﻒ ﻣﺤﻤﻲ ﺑﻜﻠﻤﺔ ﻣﺮور أو ﻣﺆﻣﻦ
ھﻞ ھﻨﺎك أي ﻓﻮاﺋﺪ ﻟﻠﻤﺸﺎرﻛﺔ؟
ﻟﻦ ﺗﺴﺘﻔﯿﺪ ﺑﺸﻜﻞ ﻣﺒﺎﺷﺮ ﻣﻦ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬا اﻟﺒﺤﺚ

ﻣﺎ ھﻲ ﺑﺪاﺋﻞ اﻟﻤﺸﺎرﻛﺔ؟
اﻟﺒﺪﯾﻞ ھﻮ ﻋﺪم اﻟﻤﺸﺎرﻛﺔ
ھﻞ ھﻨﺎك أي ﺗﻜﺎﻟﯿﻒ ﻟﻠﻤﺸﺎرﻛﺔ؟
اﻟﻤﺸﺎرﻛﺔ ﻟﻦ ﺗﻜﻠﻔﻚ ﺷﯿﺌﺎ
ھﻞ ﺳﺄدﻓﻊ ﻣﻘﺎﺑﻞ اﻟﻤﺸﺎرﻛﺔ؟
ﻟﻦ ﯾﺘﻢ اﻟﺪﻓﻊ ﻟﻚ ﻟﻠﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ
دراﺳﺔ ﻣﻌﻠﻮﻣﺎت اﻻﺗﺼﺎل
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ﯾﻤﻜﻨﻚ  ، Afarha4@emich.edu.إذا ﻛﺎن ﻟﺪﯾﻚ أي أﺳﺌﻠﺔ ﺣﻮل اﻟﺒﺤﺚ  ،ﯾﻤﻜﻨﻚ اﻻﺗﺼﺎل ﻋﻠﯨﺎﻟﺒﺎﺣﺚ اﻟﺮﺋﯿﺴﻲ
 ، imartin2@emich.eduأﯾ ً
ﻀﺎاﻻﺗﺼﺎل ﺑﻤﺴﺘﺸﺎري  ،اﻟﺪﻛﺘﻮر إﯾﺮوﯾﻦ ﻣﺎرﺗﻦ ﻓﻲ ﺟﺎﻣﻌﺔﻣﯿﺘﺸﯿﺠﺎن اﻟﺸﺮﻗﯿﺔ

واﻟﻤﺸﺎرﻛﺔ اﻟﻄﻮﻋﯿﺔ
اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ھﻲ اﺧﺘﯿﺎرك .ﯾﻤﻜﻨﻚ رﻓﺾ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ أي وﻗﺖ  ،ﺣﺘﻰ ﺑﻌﺪ اﻟﺘﻮﻗﯿﻊ ﻋﻠﻰ ھﺬا اﻟﻨﻤﻮذج  ،د
.ون أي ﺗﺪاﻋﯿﺎت .ﯾﻤﻜﻨﻚ اﺧﺘﯿﺎر ﺗﺮك اﻟﺪراﺳﺔ ﻓﻲ أي وﻗﺖ دون أي ﺗﺪاﻋﯿﺎت
ﺑﯿﺎن اﻟﻤﻮاﻓﻘﺔ
ﻟﻘﺪ ﻗﺮأت ھﺬا اﻟﻨﻤﻮذج .ﻟﻘﺪ أﺗﯿﺤﺖ ﻟﻲ اﻟﻔﺮﺻﺔ ﻟﻄﺮح اﻷﺳﺌﻠﺔ وأﻧﺎ راض ﻋﻦ اﻹﺟﺎﺑﺎت اﻟﺘﻲ ﺗﻠﻘﯿﺘﮭﺎ .أﻋﻄﻲ ﻣﻮاﻓﻘﺘﻲ ﻟﻠﻤﺸﺎرﻛﺔ
.ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ
:اﻟﺘﻮﻗﯿﻌﺎت

____________________ ______________________________________
اﻟﺘﻮﻗﯿﻊ ﻋﻠﻰ ﺗﺎرﯾﺦ اﻟﻤﻮﺿﻮع

ﻟﻘﺪ ﺷﺮﺣﺖ اﻟﺒﺤﺚ ﻟﮭﺬا اﻟﻤﻮﺿﻮع وأﺟﺒﺖ ﻋﻠﻰ ﺟﻤﯿﻊ أﺳﺌﻠﺘﮫ .ﺳﻮف أﻋﻄﻲ ﻧﺴﺨﺔ ﻣﻦ ﻧﻤﻮذج اﻟﻤﻮاﻓﻘﺔ اﻟﻤﻮﻗﻌﺔ ﻟﮭﺬا اﻟﻤﻮﺿﻮع
.
________________________________________
اﺳﻢ اﻟﺸﺨﺺ اﻟﺤﺎﺻﻞ ﻋﻠﻰ اﻟﻤﻮاﻓﻘﺔ
_______________________ ________________________________________
ﺗﻮﻗﯿﻊ اﻟﺸﺨﺺ اﻟﺤﺎﺻﻞ ﻋﻠﻰ ﺗﺎرﯾﺦ اﻟﻤﻮاﻓﻘﺔ
واﻟﻤﺸﺎرﻛﺔ اﻟﻄﻮﻋﯿﺔ
اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ھﻲ اﺧﺘﯿﺎرك .ﯾﻤﻜﻨﻚ رﻓﺾ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ أي وﻗﺖ  ،ﺣﺘﻰ ﺑﻌﺪ اﻟﺘﻮﻗﯿﻊ ﻋﻠﻰ ھﺬا اﻟﻨﻤﻮذج  ،د
.ون أي ﺗﺪاﻋﯿﺎت .ﯾﻤﻜﻨﻚ اﺧﺘﯿﺎر ﺗﺮك اﻟﺪراﺳﺔ ﻓﻲ أي وﻗﺖ دون أي ﺗﺪاﻋﯿﺎت
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Appendix E: Survey Questions in English
Survey Questions: Please answer to the best of your ability.
1) How knowledgeable are you about clinical research?
a) Not at all knowledgeable
b) A little knowledgeable
c) Somewhat knowledgeable
d) Completely knowledgeable
2) Clinical research or clinical trials are:
a) Scientific investigations using humans to study treatment of human disease
b) Scientific investigations using animals to study treatment of human disease
c) Scientific investigations using laboratory studies to study treatment of human disease
d) Not sure
3) If given a chance, would you consider participating in a clinical research study?
a) Yes
b) No
c) Not sure
4) You might agree to be in a clinical research study:
a) If you get paid
b) To help future generations
c) Because it might be an interesting thing to do
d) To get help with your illness
5) You might not agree to participate in a research study:
a) Because you do not want to be used as a guinea pig in research
b) Because you do not know if it would be safe
c) As you simply prefer not to
d) Because you are concerned about taking an experimental drug
6) Would you take a drug that was not tested in animal or humans?
a) Yes
b) No
7) How would you like to be informed of a clinical research study you might be appropriate for?
a) From your physician
b) By reading an advertisement
c) From a government list
d) From a posting at a community site
e) Through Facebook or other social media
8) Where do you think clinical research is conducted? (Note all that apply)
a) Hospitals
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b)
c)
d)
e)

University Medical Centers
Clinics
Private Physician Office
Not sure

The following questions are for classification purposes only. As a reminder, no personal
information is identifiable.
9) Your age:
a) 18 - 24 years
b) 25 - 34 years
c) 35 - 65 years
d) 65 years or older
10) Gender?
a) Male
b) Female
c) Other/prefer not to answer
11) What is your highest level of education?
a) Less than High School
b) High School
c) Bachelor’s degree
d) Master’s degree or greater
12) What is your marital status?
a) Married
b) Single
c) Prefer not to answer
13) How long have you lived in the United States?
a) <5 years
b) 5-10 years
c) >10 years
d) You do not live in the US
14) What language do you speak at home?
a) English
b) Arabic
c) Spanish
d) French
e) other
15) How fluent are you in English?
a) Read, write and speak well
b) Understand conversational English
c) Do not speak English
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16) What is your or your parents’ country of origin?
a) US
b) Yemen
c) Iraq
d) Other Middle Eastern
e) Other
17) How long have your parents’ been a resident in the United States?
a) <5 years
b) 5-10
c) >10 years
d) Your parents do not live in the US
18) What religion does your family practice?
a) Protestant Christian
b) Catholic Christian
c) Islam
d) Judaism
e) Buddhism
f) Other or Prefer not to answer

34
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Appendix F: Survey Questions in Arabic
.أﺳﺌﻠﺔ اﻻﺳﺘﻄﻼع :اﻟﺮﺟﺎء أﺳﺌﻠﺔ اﻻﺳﺘﻄﻼع :اﻟﺮﺟﺎء اﻹﺟﺎﺑﺔ ﻋﻠﻰ أﻓﻀﻞ ﻣﺎ ﻓﻲ ﻗﺪر

ﻣﺎ ﻣﺪى ﻣﻌﺮﻓﺘﻚ ﺑﺸﺄن اﻟﺒﺤﺚ اﻟﺴﺮﯾﺮي؟
أ) ﻟﯿﺲ ﻋﻠﻰ اﻹطﻼق اﻟﻤﻌﺮﻓﺔ
ب) اﻟﻘﻠﯿﻞ ﻣﻦ اﻟﻤﻌﺮﻓﺔ
ج) ﻋﻠﻰ دراﯾﺔ إﻟﻰ ﺣﺪ ﻣﺎ
د) ﻋﻠﻰ دراﯾﺔ
:اﻟﺒﺤﻮث اﻟﺴﺮﯾﺮﯾﺔ أو اﻟﺘﺠﺎرب اﻟﺴﺮﯾﺮﯾﺔ ھﻲ )
أ) اﻟﺘﺤﻘﯿﻘﺎت اﻟﻌﻠﻤﯿﺔ ﺑﺎﺳﺘﺨﺪام اﻟﺒﺸﺮ ﻟﺪراﺳﺔ ﻋﻼج اﻷﻣﺮاض اﻟﺒﺸﺮﯾﺔ
ب) اﻟﺘﺤﻘﯿﻘﺎت اﻟﻌﻠﻤﯿﺔ ﺑﺎﺳﺘﺨﺪام اﻟﺤﯿﻮاﻧﺎت ﻟﺪراﺳﺔ ﻋﻼج اﻷﻣﺮاض اﻟﺒﺸﺮﯾﺔ
ج) اﻟﺘﺤﻘﯿﻘﺎت اﻟﻌﻠﻤﯿﺔ ﺑﺎﺳﺘﺨﺪام اﻟﺪراﺳﺎت اﻟﻤﺨﺘﺒﺮﯾﺔ ﻟﺪراﺳﺔ ﻋﻼج اﻷﻣﺮاض اﻟﺒﺸﺮﯾﺔ
د) ﻏﯿﺮ ﻣﺘﺄﻛﺪ

إذا أﺗﯿﺤﺖ ﻟﻚ اﻟﻔﺮﺻﺔ  ،ﻓﮭﻞ ﺗﻔﻜﺮ ﻓﻲ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ دراﺳﺔ ﺑﺤﺜﯿﺔ إﻛﻠﯿﻨﯿﻜﯿﺔ؟
أ) ﻧ ﻌ ﻢ
ب) ﻻ
ج) ﻏﯿﺮ ﻣﺘﺄﻛﺪ
:ﻗﺪ ﺗﻮاﻓﻖ ﻋﻠﻰ أن ﺗﻜﻮن ﻓﻲ دراﺳﺔ ﺑﺤﺜﯿﺔ إﻛﻠﯿﻨﯿﻜﯿﺔ
أ) إذا ﻛﻨﺖ ﺗﺤﺼﻞ ﻋﻠﻰ أﻣﻮال
ب) ﻣﺴﺎﻋﺪة اﻷﺟﯿﺎل اﻟﻘﺎدﻣﺔ
ج) ﻷﻧﮫ ﻗﺪ ﯾﻜﻮن ﺷﯿﺌ ًﺎ ﻣﺜﯿًﺮا ﻟﻼھﺘﻤﺎم
د) ﻟﻠﺤﺼﻮل ﻋﻠﻰ ﻣﺴﺎﻋﺪة ﺑﺸﺄن ﻣﺮﺿﻚ
أ) ﻷﻧﻚ ﻻ ﺗﺮﯾﺪ أن ﺗﺴﺘﺨﺪم ﻛﺨﻨﺰﯾﺮ ﻏﯿﻨﯿﺎ ﻓﻲ اﻟﺒﺤﺚ
ب) ﻷﻧﻚ ﻻ ﺗﻌﺮف ﻣﺎ إذا ﻛﺎﻧﺖ آﻣﻨﺔ
ج) ﻛﻤﺎ ﺗﻔﻀﻞ ﺑﺒﺴﺎطﺔ ﻋﺪم اﻟﻘﯿﺎم ﺑﺬﻟﻚ
د) ﻷﻧﻚ ﻗﻠﻖ ﺑﺸﺄن ﺗﻨﺎول ﻋﻘﺎر ﺗﺠﺮﯾﺒﻲ
:ﻗﺪ ﻻ ﺗﻮاﻓﻖ ﻋﻠﻰ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ دراﺳﺔ ﺑﺤﺜﯿﺔ )
أ) ﻷﻧﻚ ﻻ ﺗﺮﯾﺪ أن ﺗﺴﺘﺨﺪم ﻛﺨﻨﺰﯾﺮ ﻏﯿﻨﯿﺎ ﻓﻲ اﻟﺒﺤﺚ
ب) ﻷﻧﻚ ﻻ ﺗﻌﺮف ﻣﺎ إذا ﻛﺎﻧﺖ آﻣﻨﺔ
ج) ﻛﻤﺎ ﺗﻔﻀﻞ ﺑﺒﺴﺎطﺔ ﻋﺪم اﻟﻘﯿﺎم ﺑﺬﻟﻚ
د) ﻷﻧﻚ ﻗﻠﻖ ﺑﺸﺄن ﺗﻨﺎول ﻋﻘﺎر ﺗﺠﺮي
ھﻞ ﺗﺄﺧﺬ دواء ﻟﻢ ﯾﺘﻢ اﺧﺘﺒﺎره ﻓﻲ اﻟﺤﯿﻮان أو اﻟﺒﺸﺮ؟
أ) ﻧ ﻌ ﻢ
ب) ﻻ
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ﻛﯿﻒ ﺗﺮﯾﺪ أن ﺗﻜﻮن ﻋﻠﻰ ﻋﻠﻢ ﺑﺪراﺳﺔ ﺑﺤﺜﯿﺔ ﺳﺮﯾﺮﯾﺔ ﻗﺪ ﺗﻜﻮن ﻣﻨﺎﺳﺒﺔ ﻟﮭﺎ؟
أ ) ﻣﻦ ط ﺒ ﯿ ﺒ ﻚ
ب) ﻣﻦ ﺧﻼل ﻗﺮاءة اﻹﻋﻼن
ج ) ﻣﻦ ﻗ ﺎ ﺋ ﻤ ﺔ ا ﻟ ﺤ ﻜ ﻮ ﻣ ﺔ
د) ﻣﻦ ﻧﺸﺮ ﻓﻲ ﻣﻮﻗﻊ اﻟﻤﺠﺘﻤﻊ
ه) ﻣﻦ ﺧﻼل اﻟﻔﯿﺴﺒﻮك أو وﺳﺎﺋﻞ اﻟﺘﻮاﺻﻞ اﻻﺟﺘﻤﺎﻋﻲ اﻷﺧﺮى
أﯾﻦ ﺗﻌﺘﻘﺪ أن اﻟﺒﺤﻮث اﻟﺴﺮﯾﺮﯾﺔ ﺗﺘﻢ؟ (ﻻﺣﻆ ﻛﻞ ﻣﺎ ﯾﻨﻄﺒﻖ
أ) ا ﻟ ﻤ ﺴ ﺘ ﺸ ﻔ ﯿ ﺎ ت
ب) ﻣﺮاﻛﺰ اﻟﺠﺎﻣﻌﺔ اﻟﻄﺒﯿﺔ
ج) اﻟﻌﯿﺎدات
د) ﻣﻜﺘﺐ اﻟﻄﺒﯿﺐ اﻟﺨﺎص
ه) ﻏﯿﺮ ﻣﺘﺄﻛﺪ
.اﻷﺳﺌﻠﺔ اﻟﺘﺎﻟﯿﺔ ھﻲ ﻷﻏﺮاض اﻟﺘﺼﻨﯿﻒ ﻓﻘﻂ .ﻛﺘﺬﻛﯿﺮ  ،ﻻ ﯾﻤﻜﻦ اﻟﺘﻌﺮف ﻋﻠﻰ أي ﻣﻌﻠﻮﻣﺎت ﺷﺨﺼﯿﺔ
:ﻋﻤﺮك
أ) ﻣﻦ  18إﻟﻰ  24ﻋﺎًﻣﺎ
ب ) 34 - 25ﺳﻨﺔ
ج ) 65 - 35ﺳﻨﺔ
د ) 65ﺳﻨﺔ أو أﻛﺜﺮ
اﻟﺠﻨﺲ؟
ذﻛﺮ
ب) أ ﻧ ﺜ ﻰ
اﻟﺒﻌﺾ  /ﯾﻔﻀﻞ ﻋﺪم اﻻﺟﺎﺑﺔ
ﻗﻞ ﻣﻦ اﻟﻤﺪرﺳﺔ اﻟﺜﺎﻧﻮﯾﺔ
ب) اﻟﻤﺪرﺳﺔ اﻟﺜﺎﻧﻮﯾﺔ
ج) درﺟﺔ اﻟﺒﻜﺎﻟﻮرﯾﻮس
د) درﺟﺔ اﻟﻤﺎﺟﺴﺘﯿﺮ أو أﻛﺒﺮ
ﻣ ﺎ ھﻲ ﺣ ﺎ ﻟ ﺘ ﻚ ا ﻻ ﺟ ﺘ ﻤ ﺎ ﻋ ﯿ ﺔ ؟
أ) ﻣﺘﺰوج
ب) واﺣﺪ
ج) ﯾﻔﻀﻞ ﻋﺪم اﻹﺟﺎﺑﺔ
ﻣﺎ ھﻮ أﻋﻠﻰ ﻣﺴﺘﻮى ﺗﻌﻠﯿﻤﻲ؟
أ) أﻗﻞ ﻣﻦ اﻟﻤﺪرﺳﺔ اﻟﺜﺎﻧﻮﯾﺔ
ب) اﻟﻤﺪرﺳﺔ اﻟﺜﺎﻧﻮﯾﺔ
ج) درﺟﺔ اﻟﺒﻜﺎﻟﻮرﯾﻮس
د) درﺟﺔ اﻟﻤﺎﺟﺴﺘﯿﺮ أو أﻛﺒﺮ
ﻣ ﺎ ھﻲ ﺣ ﺎ ﻟ ﺘ ﻚ ا ﻻ ﺟ ﺘ ﻤ ﺎ ﻋ ﯿ ﺔ ؟
أ) ﻣﺘﺰوج
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ب) واﺣﺪ
ج) ﯾﻔﻀﻞ ﻋﺪم اﻹﺟﺎﺑﺔ
ﻣﻨﺬ ﻣﺘﻰ وأﻧﺖ ﺗﻌﯿﺶ ﻓﻲ اﻟﻮﻻﯾﺎت اﻟﻤﺘﺤﺪة؟
أ< ) 5ﺳﻨﻮات
ب ) 10-5ﺳﻨﻮات
ج >) 10ﺳﻨﻮات
د) أﻧﺖ ﻻ ﺗﻌﯿﺶ ﻓﻲ اﻟﻮﻻﯾﺎت اﻟﻤﺘﺤﺪة
ﻣﺎ اﻟﻠﻐﺔ اﻟﺘﻲ ﺗﺘﺤﺪﺛﮭﺎ ﻓﻲ اﻟﻤﻨﺰل؟
أ) اﻹﻧﺠﻠﯿﺰﯾﺔ
ب) اﻟﻌﺮﺑﯿﺔ
ج) ا ﻹ ﺳ ﺒ ﺎ ﻧ ﯿ ﺔ
د) اﻟﻔﺮﻧﺴﯿﺔ
ه) أﺧﺮى
ﻛﯿﻒ ﺗﺘﻘﻦ اﻟﻠﻐﺔ اﻹﻧﺠﻠﯿﺰﯾﺔ؟
أ) اﻟﻘﺮاءة واﻟﻜﺘﺎﺑﺔ واﻟﺘﺤﺪث ﺑﺸﻜﻞ ﺟﯿﺪ
ب) ﻓﮭﻢ اﻹﻧﺠﻠﯿﺰﯾﺔ ﻟﻠﻤﺤﺎدﺛﺔ
ج) ﻻ ﺗﺘﺤﺪث اﻹﻧﺠﻠﯿﺰﯾﺔ
ﻣﺎ ھﻮ ﺑﻠﺪ ﻣﻨﺸﺄك أو واﻟﺪك؟
أ) اﻟﻮﻻﯾﺎت اﻟﻤﺘﺤﺪة
ب) ا ﻟ ﯿ ﻤ ﻦ
ج) اﻟﻌﺮاق
د) اﻟﺸﺮق اﻷوﺳﻂ أﺧﺮى
ه) أﺧﺮى
ﻣﻨﺬ ﻣﺘﻰ ﻛﺎن واﻟﺪﯾﻚ ﻣﻘﯿﻤﺎ ﻓﻲ اﻟﻮﻻﯾﺎت اﻟﻤﺘﺤﺪة؟
أ< ) 5ﺳﻨﻮات
ب )10-5
ج >) 10ﺳﻨﻮات
د) ﻻ ﯾﻌﯿﺶ واﻟﺪﯾﻚ ﻓﻲ اﻟﻮﻻﯾﺎت اﻟﻤﺘﺤﺪة
ﻣﺎ ھﻮ اﻟﺪﯾﻦ اﻟﺬي ﺗﻤﺎرﺳﮫ ﻋﺎﺋﻠﺘﻚ؟ )19
أ) اﻟﺒﺮوﺗﺴﺘﺎﻧﺖ اﻟﻤﺴﯿﺤﻲ
ب) ﻣ ﺴ ﯿ ﺤ ﻲ ﻛ ﺎ ﺛ ﻮ ﻟ ﯿ ﻜ ﻲ
ج) ا ﻹ ﺳ ﻼ م
د) اﻟﯿﮭﻮدﯾﺔ
ه) اﻟﺒﻮذﯾﺔ
و) أﺧﺮى أو ﺗﻔﻀﻞ ﻋﺪم اﻹﺟﺎ
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Appendix G: Permission for the Site
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